2017 IO Featured Talks » Predicting response to immune checkpoint inhibition using comprehensive genomic profiling and Tumor Mutation Burden (TMB)

Allison Welsh, PhD
Senior Scientist, Genomic Science & Research
Foundation Medicine Inc.

Alley is currently a Senior Scientist at Foundation Medicine (FMI), where she balances genomic research, evaluation of new technologies, education and outreach. She did her undergraduate work at Dartmouth College, and obtained her PhD in Pathology from Yale University, studying Estrogen Receptor in breast cancer, and working to build more standardized and quantitative immunofluorescent-based diagnostics. She spent her postdoc studying single-cell sequencing of circulating tumor cells at Memorial Sloan-Kettering Cancer Center and Cold Spring Harbor Laboratory, and has since become a respected expert in the liquid biopsy field. At Foundation Medicine she is involved in a variety of research projects related to novel applications of genomic profiling for cancer patients.